Internal protein tags

US9969991B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9969991-B2
Application numberUS-201514852096-A
CountryUS
Kind codeB2
Filing dateSep 11, 2015
Priority dateSep 12, 2014
Publication dateMay 15, 2018
Grant dateMay 15, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are substantially non-luminescent peptide/polypeptide tags that are inserted internally within a protein of interest or between N-terminal and C-terminal peptides/polypeptides. Interaction of the internally-inserted tag with a complement polypeptide/peptide that is also substantially non-luminescent results in the formation a bioluminescent reporter complex.

First claim

Opening claim text (preview).

We claim: 1. A polypeptide comprising: an N-terminal segment of a protein of interest, a C-terminal segment of a protein of interest, and an internal tag between the N-terminal and C-terminal segments, wherein the internal tag comprises an amino acid sequence having less than 100% and greater than 45% sequence identity with SEQ ID NO: 2 inserted within a protein of interest; wherein a detectable bioluminescent signal is produced in the presence of a coelenterazine substrate when the internal tag contacts a polypeptide consisting of SEQ ID NO: 440 and wherein the polypeptide is not a naturally occurring polypeptide. 2. The polypeptide of claim 1 , wherein the N-terminal segment and the C-terminal segment are each at least 20 amino acids in length. 3. The polypeptide of claim 1 , wherein the amino acid sequence of the internal tag is selected from the peptides of Table 1. 4. The polypeptide of claim 1 , wherein the N-terminal segment and the C-terminal segment, if directly linked in the absence of the internal tag, comprise the sequence of a first protein of interest. 5. A nucleic acid comprising a sequence coding for a polypeptide of claim 1 . 6. A bioluminescent complex comprising: (i) the polypeptide of claim 1 ; and (ii) a second polypeptide comprising a complement polypeptide having less than 100% and greater than 45% sequence identity with SEQ ID NO: 440. 7. The bioluminescent complex of claim 6 , wherein the internal tag and the complement polypeptide have low affinity for each other. 8. The bioluminescent complex of claim 7 , wherein the second polypeptide is a fusion of the complement polypeptide and a second protein of interest. 9. The bioluminescent complex of claim 8 , wherein the fusion is an internal fusion or a traditional fusion. 10. The bioluminescent complex of claim 9 , wherein the second protein of interest has high affinity for all or a portion of the N-terminal segment and/or the C-terminal segment. 11. The bioluminescent complex of claim 7 , wherein the second polypeptide is linked to a molecule of interest. 12. The bioluminescent complex of claim 11 , wherein all or a portion of the N-terminal segment and/or the C-terminal segment has high affinity for the molecule of interest. 13. The bioluminescent complex of claim 6 , further comprising a coelenterazine substrate. 14. The bioluminescent complex of claim 6 , wherein the internal tag and the complement polypeptide have high affinity for each other. 15. The bioluminescent complex of claim 6 , wherein the second polypeptide is not a fusion polypeptide or linked to a molecule of interest. 16. The bioluminescent complex of claim 6 , wherein the amino acid sequence of the complement polypeptide is selected from the polypeptides of Table 2.

Assignees

Inventors

Classifications

  • Haloalkane dehalogenase (3.8.1.5) · CPC title

  • from mammals · CPC title

  • C12N9/14Primary

    Hydrolases (3) · CPC title

  • Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

  • containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9969991B2 cover?
Provided herein are substantially non-luminescent peptide/polypeptide tags that are inserted internally within a protein of interest or between N-terminal and C-terminal peptides/polypeptides. Interaction of the internally-inserted tag with a complement polypeptide/peptide that is also substantially non-luminescent results in the formation a bioluminescent reporter complex.
Who is the assignee on this patent?
Promega Corp
What technology area does this patent fall under?
Primary CPC classification C12N9/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).